We help pharmaceutical and biotechnology companies make better commercial decisions by speaking directly to the clinicians, payers and patients who shape treatment adoption.
Healthcare research (primary, secondary and synthesis) that turns real-world stakeholder insight into clear commercial decisions.
Primary research, secondary analysis and synthesis, built for commercial questions.
Specialist markets where access, pathways and adoption dynamics matter most.
Illustrative engagement
A biotechnology company developing a peptide-based asset intended to preserve or increase muscle mass during GLP-1-associated weight loss needed early commercial clarity before heavier investment in clinical and partnering plans.
Leveraging over 30 years of combined experience across industries
CEO & Co-Founder
Investment banking professional with experience at Investec Bank plc and FIS, combining strategic leadership, executive stakeholder management and analytical rigour developed across complex, time-critical financial transactions.
Head of Research
Qualitative healthcare researcher specialising in neurology, oncology and rare diseases. Designs and delivers insight-led research that helps pharmaceutical organisations understand the experiences, behaviours and unmet needs of patients, HCPs and wider healthcare stakeholders.
Head of Sales
Pharmaceutical commercial professional at Eli Lilly and Company, working directly with an extensive network of prescribing consultants across dermatology and rheumatology. Brings frontline insight into HCP engagement, clinical practice and healthcare decision-making.
Head of Medical & Advisory
Qualified medical doctor and former Boston Consulting Group (BCG) consultant with additional life sciences advisory experience at Princeton Biopartners, bringing scientific credibility and strategic perspective to every engagement.
Helping pharmaceutical, biotechnology and healthcare organisations make better strategic, commercial and clinical decisions through rigorous research and meaningful insight.
Every project benefits from the combined perspective of our multidisciplinary team spanning commercial strategy, medical expertise and research excellence to generate insight that supports real-world clinical decision-making.
The responsiveness of a boutique without sacrificing industry-leading quality. Our lean operating model enables faster decision-making, greater flexibility and direct communication, allowing us to adapt quickly to evolving client requirements and compressed project timelines.
Direct access to our leadership team is guaranteed throughout every engagement. Every project is led by senior specialists from initial proposal through to final presentation, ensuring consistency, accountability and exceptional quality at every stage.
Our ethos is to operate as an extension of your team, not another supplier. We integrate into existing teams and operating models. We own the delivery and risks, and ensure high-quality outcomes.
Clinical expertise is embedded throughout the research lifecycle. Medical oversight strengthens study design, discussion guides, analysis and reporting, ensuring every engagement is scientifically robust, clinically relevant and therapeutically accurate.
Research tailored to your most pressing questions. Every engagement is designed around your objectives, selecting the most appropriate qualitative, quantitative or mixed-method approach to generate meaningful, evidence-based insight.
We recognise that healthcare market research requires more than strong methodology. It also requires careful governance, transparent participant processes, appropriate data handling and clear procedures for pharmacovigilance and confidentiality.
Research activities are designed with reference to UK GDPR and the Data Protection Act 2018, including appropriate participant information, lawful processing, controlled access, retention and deletion procedures.
Our research approach is informed by the BHBIA Legal and Ethical Guidelines for Healthcare Market Research, including participant transparency, confidentiality, appropriate incentives and separation of research from promotion.
Share the commercial or development question you are facing. We will come back with a clear view on approach, markets and timing.